KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Change in Cash (2016 - 2025)

Historic Change in Cash for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $10.2 billion.

  • Merck's Change in Cash rose 20730.02% to $10.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year decrease of 4065.46%. This contributed to the annual value of $6.4 billion for FY2024, which is 20929.4% up from last year.
  • Latest data reveals that Merck reported Change in Cash of $10.2 billion as of Q3 2025, which was up 20730.02% from -$659.0 million recorded in Q2 2025.
  • In the past 5 years, Merck's Change in Cash ranged from a high of $10.2 billion in Q3 2025 and a low of -$4.6 billion during Q1 2025
  • Over the past 5 years, Merck's median Change in Cash value was $447.0 million (recorded in 2022), while the average stood at $531.9 million.
  • Its Change in Cash has fluctuated over the past 5 years, first crashed by 76823.27% in 2023, then skyrocketed by 23996.07% in 2024.
  • Merck's Change in Cash (Quarter) stood at -$1.9 billion in 2021, then skyrocketed by 179.51% to $1.5 billion in 2022, then plummeted by 217.8% to -$1.8 billion in 2023, then increased by 22.16% to -$1.4 billion in 2024, then surged by 843.58% to $10.2 billion in 2025.
  • Its Change in Cash was $10.2 billion in Q3 2025, compared to -$659.0 million in Q2 2025 and -$4.6 billion in Q1 2025.